Comments from Dr. Shefali Agarwal, President and CEO, on Agreement with Novartis

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

Sironax Accelerates Global Expansion

Sironax Story | Build the Bridge From Bench to Bedside for Degenerative Diseases

Sironax Completed Phase I study for SIR2501

Sironax Celebrates US Team Expansion And China IND Approvals

Sironax Announces Closing of $200M Series B Financing